Search

Search Language

English | Use language selector above (below, on mobile) to search additional languages

Open filter

11 items matching filters

Search Results

Insight

Telehealth Transformation: Innovating Mental Health Care
Life Sciences Snapshot – Q1 2025

11 minute read | February.19.2025

Life Sciences Snapshot – Q1 2025 – A Quarterly Report on Financing Trends

U.S. life sciences VC rebounded in 2024 with rising deal and exit value. Orrick’s Life Sciences Snapshot breaks down the key trends.

Insight

The Download: A Private Sector Model for Responsible AI in Healthcare & Why Value-Based Care Is Good Business

4 minute read | January.23.2025

In this Life Sciences & Healthtech edition of The Download, we take on key trends with the Coalition for Health AI, Aledade and BofA Securities.

Insight

FDA Proposes Draft Guidance on Assessing the Credibility of AI Models Used in Drug and Biological Product Submissions

by Georgia C. Ravitz, Shari Esfahani, Stephen Thau, Thora Johnson, Jeremy D. Sherer and Amy M. Joseph
2 minute read | January.13.2025

The FDA issued draft guidance on assessing AI model credibility for drug safety, effectiveness, and quality in regulatory decisions.

Insight

FDA Issues Draft Guidance on AI-Enabled Medical Devices

by Georgia C. Ravitz, Shari Esfahani, Stephen Thau, Thora Johnson, Jeremy D. Sherer and Amy M. Joseph
3 minute read | January.07.2025

The FDA has shared draft guidance on the design and development of AI-enabled medical devices and marketing submissions for those devices.

Insight

DEA Issues Third Extension of Telemedicine Prescribing Flexibilities

by Amy M. Joseph, Jeremy D. Sherer, Melania Jankowski and Anna Booth
2 minute read | January.02.2025

The Third Extension allows providers to continue prescribing controlled substances without a prior in-person examination through December 31, 2025.

Insight

Life Sciences Snapshot – Q4 2024 – A Quarterly Report on Financing Trends

14 minute read | December.20.2024

Healthtech Horizons: Navigating Regulation, Investment, and Strategy in a Transforming Market

Insight

U.S. States Begin Regulating Generative Artificial Intelligence in Health Care

by Amy M. Joseph, Jeremy D. Sherer, Emily Brodkin and Melania Jankowski
3 minute read | October.03.2024

ai and healthcare - healthtech - digital life sciences icons

The health care industry has used AI for decades, but the rise of generative AI raises questions about how to regulate the technology.

Insight

Texas Attorney General Reaches Novel Generative AI Settlement: What Health Tech Companies Need to Know

by Thora Johnson, Alyssa Wolfington, Amy M. Joseph, Jeremy D. Sherer, Emily Brodkin and Melania Jankowski
3 minute read | September.24.2024

The Texas Attorney General is once again signaling the office’s intent to enforce the state’s privacy and consumer protection laws.

Insight

Orrick Speaks: Jeremy Sherer Explores California AI Legislation with Modern Healthcare

by Jeremy D. Sherer
1 minute read | September.23.2024

Proposed AI legislation in California may have big implications in health care.

Insight

Federation of State Medical Boards Weighs In on Ethical Use of AI in Clinical Practice

by Amy M. Joseph and Jeremy D. Sherer
5 minute read | September.04.2024

Though responsible and ethical use of artificial intelligence (AI) has been a hot topic for the past few years, there has not yet been significant ...

Insight

Increased Scrutiny of Private Investment in Health Care: Key Insights for Health Care Innovators and Investors

by Amy M. Joseph and Jeremy D. Sherer
7 minute read | August.15.2024

stethoscope and notebook with chart overlay

Federal agencies and lawmakers in several states are attempting to rewrite the rulebook for private investment in health care in the U.S.